However, beneficial impact of GLP-1 on endothelial function and microcirculatory integrity in patients with CAD have been described
Remember that every step forwardno matter how smallbrings you closer to your ideal self
Reducing Glucagon Secretion: GLP-1 inhibits the secretion of glucagon, a hormone that increases blood sugar levels by promoting the release of glucose from the liver
People with a history of pancreatitis Those with severe gastrointestinal disorders Individuals with h/o thyroid cancers or MEN syndrome Pregnant or breastfeeding women Seeking advice from your doctor is vital before initiating therapy
Discussion In this study, we aimed to understand if people with T2D, who were newly prescribed GLP-1 RAs labeled for T2D, were initiating treatment at markers indicative of lower disease severity
doi: 10.1002/phar.1507 [DOI] [PubMed] [Google Scholar] 85.Jiang Y, Liu J, Chen X, et al